References
- Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol. 1999;44:187–213.
- Shafi F, Mathewson P, Mehta P, Ahluwalia HS. The enlarged extraocular muscle: to relax, reflect or refer? Eye (Lond). 2017;31(4):537–544. doi:10.1038/eye.2016.248.
- Mehta P, Chickadasarahally S, Hedley N, Ahluwalia H. Extraocular muscle enlargement as a paraneoplastic effect of breast carcinoma in a male patient. Ophthalmic Plast Reconstr Surg. 2011;27(6):e146–147. doi:10.1097/IOP.0b013e3182078e31.
- Harris GJ, Murphy ML, Schmidt EW, Hanson GA, Dotson RM. Orbital myositis as a paraneoplastic syndrome. Arch Ophthalmol. 1994;112:380–386.
- Guiney M, Buckley C, Radford N, Joyce G. A case of seminoma-associated orbitopathy. Aust N Z J Ophthalmol. 1995;23:335–337.
- Spraul CW, Lang GE, Lang GK. Orbital myopathy in metastatic malignant paraganglioma: a paraneoplastic syndrome? Klin Monbl Augenheilkd. 1996;209(2–3):153–157. doi:10.1055/s-2008-1035296.
- Dolman PJ. Evaluating Graves’ orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26(3):229–248. doi:10.1016/j.beem.2011.11.007.
- Rothfus WE, Curtin HD. Extraocular muscle enlargement: a CT review. Radiology. 1984;151(3):677–681. doi:10.1148/radiology.151.3.6546996.
- Trokel SL, Hilal SK. Recognition and differential diagnosis of enlarged extraocular muscles in computed tomography. Am J Ophthalmol. 1979;87:503–512.
- Patrinely JR, Osborn AG, Anderson RL, Whiting AS. Computed tomographic features of nonthyroid extraocular muscle enlargement. Ophthalmology. 1989;96:1038–1047.
- Taylor JB, Solomon DH, Levine RE, Ehrlich RM. Exophthalmos in seminoma. Regression with steroids and orcheictomy. JAMA. 1978;240:860–862.
- Mann AS. Bilateral exophthalmos in seminoma. J Clin Endocrinol Metab. 1967;27(10):1500–1502. doi:10.1210/jcem-27-10-1500.
- Fukushima M, Hatanaka R, Tsushima T, et al. A case of squamous cell carcinoma of the lung associated with exophthalmos and hypercalcemia. Kyobu Geka. 1998;51:168–173.
- Diacon AH, Schuurmans MM, Colesky FJ, Bolliger CT. Paraneoplastic bilateral proptosis in a case of non-small cell lung cancer. Chest. 2003;123:627–629.
- Finol HJ, Marquez A, Navas E, de Navas NR. Extraocular muscle ultrastructural pathology in the paraneoplastic phenomenon associated with retinoblastoma. J Exp Clin Cancer Res. 2001;20:281–285.
- Eckel F, Ugi I, Schmidt T, Lersch C. A 44-year-old patient with cardial carcinoma and paraneoplastic orbital disease. Dtsch Med Wochenschr. 1998;123:1103–1106.
- Swash M. Acute fatal carcinomatous neuromyopathy. Arch Neurol. 1974;30:324–326.
- Mariampillai AI, Cruz JPD, Suh J, Sivapiragasam A, Nevins K, Hindenburg AA. Cancer antigen 72-4 for the monitoring of advanced tumors of the gastrointestinal tract, lung, breast and ovaries. Anticancer Res. 2017;37(7):3649–3656. doi:10.21873/anticanres.11735.
- Wang W, Xu X, Tian B, et al. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer. Clin Chim Acta. 2017;470:51–55. doi:10.1016/j.cca.2017.04.023.
- Gonssaud B, Goussot V, Berriolo-Riedinger A, et al. Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer. Ann Biol Clin (Paris). 2017;75(4):421–429. doi:10.1684/abc.2017.1257.
- Maccio G, Goussot V, Berriolo-Riedinger A, Riedinger JM. Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3. Ann Biol Clin (Paris). 2017;75(4):431–441. doi:10.1684/abc.2017.1258.
- Capone A Jr., Slamovits TL. Discrete metastasis of solid tumors to extraocular muscles. Arch Ophthalmol. 1990;108:237–243.
- Bullock JD, Yanes B. Ophthalmic manifestations of metastatic breast cancer. Ophthalmology. 1980;87:961–973.
- Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol. 1974;92:276–286.
- Rose C, Dose J, Avril N. Positron emission tomography for the diagnosis of breast cancer. Nucl Med Commun. 2002;23:613–618.